WNK2 and pancreatic ductal adenocarcinoma: WNK2 was also found to be downregulated via epigenetic silencing in early pancreatic ductal adenocarcinoma and may support cell proliferation through the Mitogen‐activated protein kinase (MAPK) signaling pathway [30].